logo

AMRN

Amarin·NASDAQ
--
--(--)
--
--(--)
1.72 / 10
Underperform

Fundamentally, Amarin is rated Underperform with a 1.7/10 score. Inventory turnover and interest coverage are strengths, but current liabilities ratio and YoY revenue decline are weak, resulting in constrained appraisal.

Fundamental(1.72)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-2.55
Score2/3
Weight36.09%
1M Return4.88%
Total operating revenue (YoY growth rate %)
Value-6.55
Score1/3
Weight-2.23%
1M Return-0.38%
Inventory turnover ratio
Value0.51
Score3/3
Weight-5.59%
1M Return-0.93%
Current liabilities / Total liabilities (%)
Value91.95
Score1/3
Weight-9.08%
1M Return-1.69%
PB-ROE
Value7.55
Score1/3
Weight45.98%
1M Return7.56%
Long-term debt to working capital ratio (%)
Value0.04
Score2/3
Weight-2.01%
1M Return-0.35%
Interest coverage ratio (EBIT / Interest expense) (%)
Value35.11
Score2/3
Weight-6.60%
1M Return-1.17%
Operating revenue (YoY growth rate %)
Value-6.55
Score1/3
Weight-1.75%
1M Return-0.30%
Cost of sales ratio (%)
Value43.43
Score2/3
Weight-6.23%
1M Return-1.13%
Asset-MV
Value-0.55
Score1/3
Weight51.41%
1M Return6.31%
Is AMRN undervalued or overvalued?
  • AMRN scores 1.72/10 on fundamentals and holds a Premium valuation at present. Backed by its -8.21% ROE, -18.16% net margin, -7.90 P/E ratio, 0.67 P/B ratio, and 55.00% earnings growth, these metrics solidify its Underperform investment rating.